Immatics N.V.

General ticker "IMTX" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $903.6M (TTM average)

Immatics N.V. does not follow the US Stock Market performance with the rate: -9.6%.

Estimated limits based on current volatility of 4.0%: low 4.17$, high 4.52$

Factors to consider:

  • Price in estimated range

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [4.13$, 9.10$]
  • 2025-12-31 to 2026-12-31 estimated range: [3.73$, 8.19$]

Financial Metrics affecting the IMTX estimates:

  • Positive: 0.04 < Non-GAAP EPS, $ of 0.14
  • Negative: Operating cash flow per share per price, % of -17.18 <= 1.79
  • Positive: -3.20 < Investing cash flow per share, $ of -1.50
  • Positive: Industry inventory ratio change (median), % of 0 <= 0
  • Negative: Industry operating cash flow per share per price (median), % of -21.10 <= 2.82
  • Negative: negative Operating income
  • Negative: Industry earnings per price (median), % of -27.42 <= 0
  • Positive: -1.21 < Return on assets ratio (scaled to [-100,100]) of 2.14
  • Negative: Inventory ratio change, % of 46.30 > 1.05

Similar symbols

Short-term IMTX quotes

2025-03-102025-03-112025-03-122025-03-132025-03-142025-03-172025-03-182025-03-192025-03-202025-03-212025-03-242025-03-252025-03-262025-03-272025-03-282025-03-312025-04-012025-04-022025-04-032025-04-042025-04-072025-04-082025-04-092025-04-102025-04-112025-04-142025-04-152025-04-162025-04-172025-04-213.544.555.5
Price $

Long-term IMTX plot with estimates

468101214Jul 2023Jan 2024Jul 2024Jan 2025Jul 2025Jan 2026Jul 2026Jan 2027−0.200.20.4
IMTXS&P500Health CareNon-GAAP EPS EstimateNon-GAAP EPS ActualPrice $Non-GAAP EPS $

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue €172.83MM €54.00MM €155.84MM
Operating Expenses €142.88MM €155.72MM €194.45MM
Operating Income €29.95MM €-101.72MM €-38.62MM
Non-Operating Income €12.08MM €4.73MM €59.96MM
Interest Expense €8.28MM €0.83MM €0.89MM
R&D Expense €106.78MM €118.66MM €148.08MM
Income(Loss) €42.04MM €-96.99MM €21.35MM
Taxes €4.55MM €-2.35MM €6.13MM
Profit(Loss)* €37.51MM €-96.99MM €15.22MM
Stockholders Equity €213.16MM €225.08MM €574.84MM
Inventory €0.00MM €0.00MM €0.00MM
Assets €407.82MM €509.96MM €696.15MM
Operating Cash Flow €100.13MM €18.23MM €-158.03MM
Capital expenditure €6.21MM €30.96MM €16.48MM
Investing Cash Flow €-209.79MM €-31.39MM €-152.39MM
Financing Cash Flow €123.71MM €84.52MM €319.68MM
Earnings Per Share** €0.56 €-1.20 €0.14

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.